Shire Plc Medication

Shire Plc Medication

Simon Dawson/Bloomberg

AbbVie Inc. agreed to buy Shire Plc for about 32 billion pounds ($54.8 billion), becoming the latest U.S. health-care company to shift its tax residence abroad in a record surge in industry deals.